✦ LIBER ✦

Model for end-stage liver disease versus the Child-Pugh score in predicting the post-transplant 3-month and 1-year mortality in a cohort of Chinese recipients

✍ Scribed by Zhiyong Guo; Xiaoshun He; Linwei Wu; Weiqiang Ju; Anbin Hu; Qiang Tai; Dongping Wang; Yi Ma; Guodong Wang; Xiaofeng Zhu; Jiefu Huang

Book ID: 113049363
Publisher: Springer
Year: 2009
Tongue: English
Weight: 207 KB
Volume: 40
Category: Article
ISSN: 1436-2813
DOI: 10.1007/s00595-009-4114-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ADAMTS13 activity may predict the cumula

ADAMTS13 activity may predict the cumulative survival of patients with liver cirrhosis in comparison with the Child-Turcotte-Pugh score and the Model for End-Stage Liver Disease score

✍ Hiroaki Takaya; Masahito Uemura; Yoshihiro Fujimura; Masanori Matsumoto; Tomomi 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 687 KB

Proposal of a modified Child-Turcotte-Pu

Proposal of a modified Child-Turcotte-Pugh scoring system and comparison with the model for end-stage liver disease for outcome prediction in patients with cirrhosis

✍ Teh-Ia Huo; Han-Chieh Lin; Jaw-Ching Wu; Fa-Yauh Lee; Ming-Chih Hou; Pui-Ching L 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 224 KB 👁 1 views

The model for end-stage liver disease (MELD) has a better predictive accuracy for survival than the Child-Turcotte-Pugh (CTP) system and has been the primary reference for organ allocation in liver transplantation. The CTP system, with a score range of 5-15, has a ceiling effect that may compromise

The 1-year and 3-month prognostic utilit

The 1-year and 3-month prognostic utility of the AST/ALT ratio and model for end-stage liver disease score in patients with viral liver cirrhosis

✍ Edoardo Giannini; Federica Botta; Emanuela Testa; Paola Romagnoli; Simone Polega 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 82 KB

Model for the end-stage liver disease an

Model for the end-stage liver disease and death prediction in a cohort of Brazilian patients on the waiting list for liver transplantation

✍ Ajacio Brandão; Sandra C Fuchs; Ana L Gleisner; Claudio Marroni; Maria L Zanotel 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB

The value of model for end-stage liver d

The value of model for end-stage liver disease and Child–Turcotte–Pugh scores over time in evaluating the prognosis of patients with decompensated cirrhosis: experience in the Chinese mainland

✍ Cai-qun Bie; Dong-hua Yang; Shao-hui Tang; Wei Huang 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 259 KB

Cost of a quality-adjusted life year in

Cost of a quality-adjusted life year in liver transplantation: The influence of the indication and the model for end-stage liver disease score

✍ Fredrik Åberg; Suvi Mäklin; Pirjo Räsänen; Risto P. Roine; Harri Sintonen; Anna- 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB 👁 1 views

Cost issues in liver transplantation (LT) have received increasing attention, but the cost-utility is rarely calculated. We compared costs per quality-adjusted life year (QALY) from the time of placement on the LT waiting list to 1 year after transplantation for 252 LT patients and to 5 years after